Get the Stockscreener App
35.30
2.00%
-0.76
Sionna Therapeutics Inc stock is traded at $35.30, with a volume of 138.16K.
It is down -2.00% in the last 24 hours and up +17.76% over the past month.
Sionna Therapeutics Inc is a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) patients by developing novel medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator (CFTR) protein to deliver clinically meaningful benefit to CF patients. CF is a progressive and life-threatening genetic disease caused by inherited mutations in the CFTR gene, which heads to insufficient CFTR function. The Company is managed as one operating segment focused on the research and development of cystic fibrosis therapies.
See More
Previous Close:
$36.06
Open:
$35.35
24h Volume:
138.16K
Relative Volume:
0.49
Market Cap:
$1.55B
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-10.42%
1M Performance:
+17.76%
6M Performance:
+160.23%
1Y Performance:
+0.00%
1-Day Range:
$33.99
$36.63
1-Week Range:
$33.99
$39.99
52-Week Range:
$7.255
$43.20
Sionna Therapeutics Inc Stock (SION) Company Profile
Name
Sionna Therapeutics Inc
Sector
Industry
Phone
617-819-2020
Address
21 HICKORY DRIVE, SUITE 500, WALTHAM
Compare SION with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SION
Sionna Therapeutics Inc
|
35.21 | 1.59B | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.71 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.02 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
422.22 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
835.98 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.98 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Sionna Therapeutics Inc Stock (SION) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-03-25 | Initiated | RBC Capital Mkts | Sector Perform |
| Sep-03-25 | Initiated | Raymond James | Strong Buy |
| Mar-04-25 | Initiated | Guggenheim | Buy |
| Mar-04-25 | Initiated | Stifel | Buy |
| Mar-04-25 | Initiated | TD Cowen | Buy |
Sionna Therapeutics Inc Stock (SION) Latest News
Sionna Therapeutics to Participate in Upcoming November Investor Conferences - GlobeNewswire
What Fibonacci levels say about Sionna Therapeutics Inc. reboundTrade Ideas & Safe Swing Trade Setup Alerts - newser.com
Will Sionna Therapeutics Inc. rebound enough to break evenJuly 2025 Decliners & Short-Term Trading Opportunity Alerts - newser.com
How analysts rate Sionna Therapeutics Inc. stock todayJuly 2025 Big Picture & Technical Buy Zone Confirmations - newser.com
Will a bounce in Sionna Therapeutics Inc. offer an exitMarket Risk Report & Consistent Income Trade Recommendations - newser.com
What Wall Street predicts for Sionna Therapeutics Inc. stock priceTrade Risk Assessment & AI Powered Market Entry Ideas - newser.com
Is Sionna Therapeutics Inc. stock a safe buy before earningsJuly 2025 Technicals & Verified Momentum Stock Watchlist - newser.com
How to build a dashboard for Sionna Therapeutics Inc. stockTrade Performance Summary & Long-Term Capital Growth Ideas - newser.com
Relative strength of Sionna Therapeutics Inc. in sector analysisGap Up & Breakout Confirmation Trade Signals - newser.com
Will Sionna Therapeutics Inc. stock go up soonEarnings Performance Report & Capital Efficiency Focused Ideas - newser.com
Can technical indicators confirm Sionna Therapeutics Inc.’s reversalMarket Activity Recap & Free Weekly Chart Analysis and Trade Guides - newser.com
Sionna Therapeutics Inc. stock chart pattern explainedJuly 2025 Highlights & Reliable Breakout Forecasts - newser.com
Is Sionna Therapeutics Inc. stock a safe haven assetChart Signals & Safe Capital Investment Plans - newser.com
Sionna Therapeutics, Inc. $SION Shares Sold by Jennison Associates LLC - MarketBeat
Why Sionna Therapeutics Inc. stock attracts global investorsTrade Ideas & Verified Technical Trade Signals - newser.com
Applying Wyckoff theory to Sionna Therapeutics Inc. stockJuly 2025 Drop Watch & Daily Stock Trend Reports - newser.com
Sionna Therapeutics Inc. stock trendline breakdown2025 AllTime Highs & Low Drawdown Investment Ideas - newser.com
Sionna Therapeutics Advances Phase 1 Study for Cystic Fibrosis Treatment - TipRanks
Insider Selling: Sionna Therapeutics (NASDAQ:SION) Director Sells 62,610 Shares of Stock - MarketBeat
Sionna Therapeutics (NASDAQ:SION) Director Sells $12,284,500.00 in Stock - MarketBeat
What analysts say about Sionna Therapeutics Inc stockVolume Analysis Techniques & Next-Level Stock Intelligence, Now Free - earlytimes.in
Should You Hold or Sell IMP Powers Limited Stock Expert PerspectivesSector-Based Investing & Small Entry Capital Stocks - earlytimes.in
Sionna Therapeutics Inc Stock (SION) Financials Data
There is no financial data for Sionna Therapeutics Inc (SION). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
Sionna Therapeutics Inc Stock (SION) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | Director |
Oct 28 '25 |
Sale |
39.58 |
62,610 |
2,478,104 |
209,391 |
1.14%
0.42%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):